OXURION (EBR:OXUR) | WebDisclosure

PRESS RELEASE

published on 06/04/2025 at 18:00, 1 year 3 months ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en blijft onder drempel van 5%. Bedrijf combineert therapeutische innovatie met technologieën in klinisch onderzoek

Transparantiekennisgeving Aandelen Oxurion NV Biofarmaceutisch Innovatie
PRESS RELEASE

published on 06/04/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV has received a transparency notification from Atlas Special Opportunities II, LLC indicating a change in shareholding, crossing under the 5% threshold

Clinical Research Transparency Notification Biopharmaceutical Shareholding Change Oxurion NV
BRIEF

published on 05/28/2025 at 18:05, 1 year 3 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Transparency Notification Biopharmaceutical Industry Voting Securities Oxurion Shares Atlas Holdings
BRIEF

published on 05/28/2025 at 18:05, 1 year 3 months ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Industrie Biopharmaceutique Notification De Transparence Titres Avec Droit De Vote Actions Oxurion Atlas Holdings
PRESS RELEASE

published on 05/28/2025 at 18:00, 1 year 3 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications from Atlas Special Opportunities II, LLC regarding shareholding thresholds pursuant to Belgian Transparency legislation

Oxurion NV Shareholding Thresholds Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II LLC
PRESS RELEASE

published on 05/28/2025 at 18:00, 1 year 3 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelenbezit volgens Belgische wetgeving. Bedrijf combineert therapeutische innovatie met klinisch onderzoekstechnologieën

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Bedrijf Belgische Wetgeving Atlas Special Opportunities II LLC
BRIEF

published on 05/22/2025 at 18:05, 1 year 4 months ago

Résultats de l'Assemblée Générale d'Oxurion

Actionnaires Assemblée Générale Titres Déclarations Prospectives Oxurion
BRIEF

published on 05/22/2025 at 18:05, 1 year 4 months ago

Results of the Oxurion General Meeting

Securities Shareholders Forward-looking Statements General Assembly Oxurion
PRESS RELEASE

published on 05/22/2025 at 18:00, 1 year 4 months ago

Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 13 mei 2025
Oxurion NV hield succesvol zijn jaarlijkse aandeelhoudersvergadering op 13 mei 2025. Alle agenda-items werden goedgekeurd. Meer informatie beschikbaar op www.oxurion.com

Euronext Brussel Oxurion NV Aandeelhoudersvergadering Biofarmaceutisch België
PRESS RELEASE

published on 05/22/2025 at 18:00, 1 year 4 months ago

Oxurion Announces Results on the Annual Shareholders' Meeting of 13 May 2025
Oxurion NV held its annual shareholders' meeting on May 13, 2025, in Leuven, Belgium. Shareholders approved all agenda items. Find more on Oxurion's website

Biopharmaceutical Clinical Data Euronext Brussels Annual Shareholders' Meeting Oxurion NV

Published on 09/26/2026 at 01:00, 11 hours 15 minutes ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 11 hours 15 minutes ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 14 hours ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 18 hours 45 minutes ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 21 hours 15 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

Published on 09/26/2026 at 07:45, 4 hours 30 minutes ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 12 hours 13 minutes ago

Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 17 hours 45 minutes ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 18 hours ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 18 hours 15 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26

View all EQS

Published on 09/26/2026 at 07:00, 5 hours 15 minutes ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 18 hours 15 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 18 hours 15 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 18 hours 30 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 18 hours 35 minutes ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE

News